{"id":"W2334434334","doi":"10.1158/1538-7445.am2013-5515","title":"Abstract 5515: <i>In vivo</i> efficacy of the PARG inhibitor Gallotannin against triple negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Cancer; Breast cancer; Cell growth; Cyclin D1; In vivo; Cell cycle checkpoint; Cancer cell; Biology; Cell cycle; Medicine; Internal medicine; Oncology; Chemistry; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002104795,0.0006135008,0.0003975896,0.0004316079,0.0001487603,0.0002327763,0.000296059,0.000465653,0.002455366],"category_scores_gemma":[0.0001228381,0.0001730639,0.0003217496,0.0002464931,0.0002518991,0.0002280901,0.0001015086,0.0008974086,0.0004887466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003498127,"about_ca_system_score_gemma":0.0002876988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001519577,"about_ca_topic_score_gemma":0.001447115,"domain_scores_codex":[0.99986,0.00003714698,0.00001029778,0.00002342297,0.00002201528,0.00004708675],"domain_scores_gemma":[0.9999045,0.00002022975,0.00002186633,0.00001264354,0.000007839859,0.00003294229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004494122,0.001136406,0.0002171668,0.0001704536,0.00004896214,0.00008213711,0.00002925576,0.0003722668,0.9856455,0.0001747369,0.0009485003,0.006680452],"study_design_scores_gemma":[0.0007384738,0.01964841,0.005653429,0.00002072352,0.000100057,0.0002174167,0.00002893915,0.00126485,0.9690431,0.00007836211,0.003195092,0.00001107679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842077,0.004165486,0.001333645,0.0005367388,0.0001959119,0.0002336787,0.002087992,0.0003352953,0.006903457],"genre_scores_gemma":[0.9918088,0.001448699,0.001112323,0.000219071,0.00003084623,0.0001475084,0.002086827,0.00004455416,0.003101417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002455366,"threshold_uncertainty_score":0.008213997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05933927053811688,"score_gpt":0.4147771849554307,"score_spread":0.3554379144173138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}